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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The objectives of this review will be to:
1. assess the efficacy of couple and family therapies for adult PTSD, relative to ’no treatment’ conditions, ’standard care’, and
structured or non-specific individual psychological therapies;
2. examine the clinical characteristics of studies that influence the relative efficacy of these therapies; and
3. critically evaluate methodological features of studies that bias research findings.
B A C K G R O U N D
Description of the condition
Post-traumatic stress disorder (PTSD) refers to an anxiety or
trauma and stressor related disorderwhere symptomonset is linked
to personal or vicarious exposure to traumatic events. These in-
clude events characterised by death or threatened death, sexual
violence, as well as actual or threatened serious injury (American
Psychiatric Association 2013). The previous fourth edition of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV
TR) (American Psychiatric Association 2000), which is most com-
monly used in currently available research, defines three categories
of psychiatric symptoms that may indicate a diagnosis of PTSD.
These include:
1. intrusive re-experiencing of the event (e.g., through
flashbacks and dreams);
2. avoidance of reminders and emotional numbing; and
3. persistent high levels of arousal and reactivity (e.g.,
hypervigilance to threat).
These symptom clusters have been re-organised in the recent fifth
edition of the Diagnostic and Statistical Manual of Mental Dis-
orders (DSM-5) (American Psychiatric Association 2013), which
now identifies four categories of PTSD symptoms:
1. intrusion;
2. avoidance;
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3. negative alterations in cognitions and mood; and
4. alterations in arousal and reactivity.
The revised system thus re-positions emotional numbing in a cat-
egory that also includes negative cognitions (e.g., self-blame) and
emotions, while arousal symptoms are repositioned in a category
including irritable and reckless or self-destructive behaviour (the
latter are new symptoms). Notwithstanding these revisions, the
fundamental construct built into the updated criteria is unchanged
(Friedman 2011), whereby close comparability between DSM-IV
and DSM-5 diagnoses is expected (Regier 2013). Current data
suggest a lifetime prevalence of PTSD around 8% in the general
population (Kessler 1995), and indicates a disorder that often fol-
lows a chronic course (Orcutt 2004; Solomon 2006). PTSD is
also associated with a range of adverse individual outcomes (e.g.,
poor health, suicidality) (Sareen 2007), as well as significant in-
terpersonal problems, including difficulties in intimate and family
relationships (Taft 2011).
Most evidence linking PTSD to family problems is derived from
studies of military veterans, from Europe and the United States,
which document associations among post-traumatic symptoms
and various adverse relationship outcomes (Galovski 2004). These
include low relationship satisfaction (Goff 2007), family violence
(Glenn 2002), and family members’ own mental health problems
(Jordan 1992). Comparative investigations of other trauma popu-
lations are relatively few, but also suggest links between PTSD and
problems in intimate relationships. For example, studies following
natural disasters indicate relations between post-traumatic symp-
toms and poor relationship adjustment (e.g., Taft 2009), while
PTSD following interpersonal victimisation predicts family vio-
lence (e.g., Krause 2006). Studies of survivors of childhood sexual
abuse also suggest problems with intimate relationships in adult-
hood (e.g., Cloitre 1997; Lamoureux 2012), including specific
difficulties with intimacy and sexual dysfunction (Davis 2000).
However, the unique influences of PTSD in the development of
these long-term problems remain poorly understood.
The inter-relations among PTSD and family problems are likely
to be complex, reflecting both the impact of post-traumatic symp-
toms on other family members, and effects of the family envi-
ronment on PTSD. On the one hand, avoidance symptoms may
reduce involvement in family activities, while emotional numb-
ing can inhibit self-disclosure and intimacy (Erbes 2008). Hy-
perarousal symptoms are linked to irritability and anger and can
also precipitate aggression and family conflict (Taft 2007a; Taft
2007b). On the other hand, prospective studies of veterans show
that family relationships can predict change in PTSD (Evans 2009;
Evans 2010), whereby an adaptive family environment can re-
duce the severity of symptoms, or exacerbate problems if interper-
sonal patterns are dysfunctional. These inter-relations are likely
to be particularly complex when PTSD is linked to certain types
of trauma. These may include interpersonal trauma (e.g., sexual
assault), where relationships (including family relationships) are
associated with the traumatic event and the onset of symptoms,
as well as other events (e.g., natural disasters, motor vehicle acci-
dents) which impact directly on multiple family members simul-
taneously (Riggs 2009).
Description of the intervention
Evidence of associations among post-traumatic symptoms and
family difficulties has provided impetus for consideration of cou-
ple and family therapies for PTSD. General reviews of literature
on couple therapies, such as Baucom 1998 and Snyder 2006, dis-
tinguish two main classes of couple-based interventions (and by
extension, therapies working with broader family systems) when
used for individual mental health problems. These include (1)
generic therapies, developed to treat distressed relationships and
address common interpersonal problems that can exacerbate in-
dividual symptoms, and (2) disorder-specific interventions, tar-
geting interactions between interpersonal processes and specific
symptoms of the disorder or its treatment.
Snyder 2006 describes several classes of generic therapies for dis-
tressed relationships that are often considered in clinical trials.
First among these are behavioural therapies (e.g., traditional be-
havioural couple therapy) (Christensen 2004), which comprise
techniques for enhancing family members’ relationship skills in
problem solving and communication, and increasing the fre-
quency of positive interactions. Second are therapies based on psy-
chodynamic and attachment theory perspectives (e.g., insight ori-
ented marital therapy) (Snyder 1989), that are characterised by a
broad focus on developing awareness and expression of unknown
feelings, thoughts and needs that may underlie interpersonal pat-
terns (Baucom 1998). Other generic therapies are also available
(although considered less often in clinical trials) (Snyder 2006),
and can include cognitive strategies for changing ways of think-
ing about behaviours and relationships, as well as techniques for
enhancing emotional acceptance. Another general class of inter-
ventions may include ’systemic’ therapies (Coulter 2013), poten-
tially including structural and strategic family therapies that fo-
cus on changing patterns of family interaction and organisation
(Madanes 1981;Minuchin 1974). Integrative therapies draw from
multiple conceptual models (Lebow 1997).
A number of disorder-specific couple and family therapies for
PTSD have also been proposed and are reviewed by Riggs 2009.
They include therapies based on behavioural principles and oth-
ers grounded in cognitive-behavioural models or attachment the-
ory (Figley 1988; Johnson 1998; Monson 2004; Mueser 1995).
These targeted therapies are commonly oriented towards reduc-
ing partners’ distress or dysfunction in the couple relationship, as
well as promoting improvements in individual PTSD. Monson
2004, for example, propose a stand-alone cognitive-behavioural
treatment for post-traumatic symptoms and relationship function-
ing that consists of several stages of therapy. These initially de-
liver psycho-education about PTSD and relationship functioning,
and also include behavioural interventions (e.g., communication
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skills training) to address avoidance and emotional numbing in
the context of relationships. Subsequent stages comprise scheduled
activities to reduce experiential avoidance and increase positive
couple experiences, as well as dyadic cognitive interventions that
target cognitions maintaining PTSD and relationship problems
(Brown-Bowers 2012). Alternative interventions comprise adjunc-
tive therapies that are delivered alongside other primary psycho-
logical and pharmacological treatments (Sautter 2009). Most of
these interventions have been developed in the context of combat-
related PTSD (Monson 2009), with a small number (such as emo-
tionally focused therapy) proposed originally for use with victims
of sexual or physical abuse (Johnson 1998), or with traumatised
populations more generally (Figley 1988).
How the intervention might work
Given the complex inter-relations among post-traumatic symp-
toms and family adjustment, multiple mechanisms of change may
underlie the proposed effects of couple and family therapies for
PTSD. For example, interventions that enhance relationship skills
(e.g., problem solving, communication) can equip families toman-
age interpersonal difficulties (e.g., associated with avoidance of so-
cial situations) and thus minimise frustrations and family conflicts
that are linked to PTSD. Therapies which promote family mem-
bers’ mutual understanding of post-traumatic symptoms and im-
pacts on relationship dynamics (e.g., through increased sharing of
experiences) might also assist in correcting erroneous beliefs about
interpersonal behaviour (for example, a mistaken explanation for
low affective involvement in terms of disengagement from the re-
lationship, rather than emotional numbing), and further reduce
family conflict. Interventions that enhance communication, or
shared thoughts and feelings, may also facilitate enhanced self-dis-
closure and related experiences of emotional intimacy (Laurenceau
1998). These therapies will also operate through common factors
shared across different interventions (e.g., positive expectancies of
therapeutic change) (Sprenkle 2004), and other processes that are
relatively unique to specific clinical models; for example, emotion-
ally focused therapy, which is argued to work, in part, by access-
ing and reprocessing negative affect that underlies dysfunctional
patterns (Johnson 1998).
Improvements in individual functioning during therapy, includ-
ing reductions in post-traumatic symptoms, are also expected to
involve various mechanisms. In some instances, these individual
benefits may result from the reduction of significant negative ex-
changes in family relationships (e.g., reflecting high levels of crit-
icism, hostility and emotional over-involvement) that can act as
psychosocial stressors and exacerbate PTSD symptoms (Tarrier
1999). Conversely, couple and family therapies may also promote
symptom change by enabling family members to provide both
comfort and social support; the latter of which predicts positive ad-
justment to both physical health problems and psychological dis-
orders like PTSD (Dirkzwager 2003; Frasure-Smith 2000; Glass
1992; Kaniasty 2008). With reference to trauma in particular,
Johnson 1998 suggests that comforting and supportive relation-
ships provide a safe and secure ’recovery environment’ where in-
dividuals can reprocess and integrate traumatic memories, safely
experience post-traumatic symptoms (e.g., flashbacks), and learn
to regulate associated negative affective states.
Why it is important to do this review
Despite growing research on the links between PTSD and the
qualities of intimate and family relationships, there remains lim-
ited understanding of the efficacy of couple and family therapies
for PTSD in adults. As far as can be ascertained, there is only
one existing Cochrane systematic review that has considered fam-
ily-based therapies (among others) for PTSD (Gillies 2012), and
this review did not consider adult samples (but rather, focused
on children and adolescents). Other Cochrane reviews of inter-
ventions for PTSD in adults have considered psychological ther-
apies (Bisson 2007), pharmacological treatments (Stein 2006), as
well as combinedpharmacological andpsychological interventions
(Hetrick 2010). None of these have considered couple or family
therapies. Other relevant Cochrane reviews have focused on pre-
vention of PTSD and treatment of distress immediately (i.e., one
to three months) following trauma exposure (Roberts 2009; Rose
2002). The currently proposed review will thus provide the first
focused examination of best quality clinical trials of couple and
family therapies for PTSD in adults.
O B J E C T I V E S
The objectives of this review will be to:
1. assess the efficacy of couple and family therapies for adult
PTSD, relative to ’no treatment’ conditions, ’standard care’, and
structured or non-specific individual psychological therapies;
2. examine the clinical characteristics of studies that influence
the relative efficacy of these therapies; and
3. critically evaluate methodological features of studies that
bias research findings.
M E T H O D S
Criteria for considering studies for this review
Types of studies
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Eligible studies will be randomised controlled trials (RCTs) of cou-
ple or family therapies for PTSD, or associated family difficulties,
in adult samples. Cross-over trials are not expected in this context,
but we will include them if couples or families are randomly al-
located to treatment sequence. Cluster-randomised trials will also
be eligible. We will not use sample size and language of the report
to determine inclusion, and there will be no restrictions on the
study settings that are eligible for the review. We will not consider
quasi-randomised trials (using non-random forms of allocation to
groups, such as sequential allocation) for inclusion.
Types of participants
Participants will be intact couples or families, comprised of family
members of any ethnicity or sexual orientation, in which at least
one adult family member (over the age of 18 years) meets criteria
for PTSD. Consistent with Lebow 2012, we will define couples
as “long-term committed unions of romantic partners whether or
not these unions are recognised by the state”; thus including gay
and lesbian and other long-standing relationships, irrespective of
formal recognition as ’married’. We will define a family as a couple
with one ormore children. In all cases one adultwill be identified as
suffering PTSD. It will be required that participants are diagnosed
with PTSD according to recognised classification systems, includ-
ing the International Classification of Diseases (ICD)-10 (WHO
2010), DSM-IV and DSM-5 (American Psychiatric Association
2000; American Psychiatric Association 2013). Assessment strate-
gies considered appropriate for ascertainment of PTSD criteria
will include general clinical interviews (e.g., based on DSM cri-
teria) and structured clinical interviews (e.g., Clinician Adminis-
tered PTSD Scale) (Blake 1995). We will also consider self-report
assessment tools (e.g., PTSD Checklist; Weathers 1993) with val-
idated clinical cut-offs.
Although we will consider studies of diverse family structures,
it is expected that most participants will be adult couples who
are intimate partners in marital or common law relationships.
Studies where intimate partners are divorced or separated will not
be considered. Studies of treatments for child or adolescent PTSD,
or therapies that focus mainly on family violence are also out of
scope.
Types of interventions
Experimental interventions
The review will consider any type of therapy that is intended to
treat intact couples or families where at least one adult family
member meets criteria for PTSD. We intend to evaluate several
main categories of therapies as follows.
1. Cognitive-behavioural therapies: this category of
interventions will include therapies based predominantly on
behavioural and cognitive-behavioural approaches to treatment
(Figley 1988; Monson 2004). Interventions based on pure
cognitive approaches would also be classified under this category
of therapy.
2. Psychodynamic therapies: this category of interventions will
include therapies based predominantly on psychodynamic
approaches to treatment. This may include emotion-focused and
insight-oriented therapies (Johnson 1998; Snyder 1989).
3. Systemic therapies: this category of interventions will
include therapies derived generally from general systems theory
approaches to treatment (von Bertalanffy 1969). It will include
structural therapies as well as strategic therapies, among others
(Coulter 2013; Madanes 1981; Minuchin 1974), and
interventions that draw from multiple systemic frameworks.
4. Integrative therapies: this category of interventions will
include therapies that include components of treatment drawn
from multiple conceptual models (Lebow 1997), including those
listed above. Where potential integrative therapies are apparent,
there will be initial efforts to classify the therapy as
predominantly one type of treatment (where around 80% of
sessions are dedicated to one component of treatment). Where it
is not possible to classify one predominant type of treatment, the
intervention will be classified as an integrative therapy.
We will consider additional categories of interventions as stud-
ies become available. Eligible therapies will be delivered as ’stand-
alone’ treatments, as well as ’adjunctive’ therapies delivered in con-
junction with other primary treatments (e.g., individual psycho-
logical therapy). We will include disorder-specific interventions
developed for treatment of PTSD or associated family difficulties
(Riggs 2009). We will also consider generic therapies for relation-
ship discord that are delivered in the context of family members
diagnosed with PTSD (Snyder 2006).
For the purpose of this review, it is required that interventions will
be delivered by psychiatrists, psychologists, counsellors, nurses or
other health professionals with specialist training in family ther-
apy (including students under supervision). Our review scope is
focused on therapies that work directly with intact couples or
families and studies where patients mainly attend therapy sessions
alone will not be considered.
Control conditions
The review will consider a range of control comparators including
’no treatment’ controls, ’standard care’, and structured or non-
specific individual psychological therapies.
For the purpose of this review, no treatment control conditions
will refer mainly to wait-list and assessment only controls.
Standard care will refer to a heterogeneous category of existing
treatments or clinical practices that may be non-specific and de-
scribed variously as ’existing practice’, ’treatment as usual’ or ’usual
care’ (Freedland 2011). These may involve relatively rigorous con-
ditions (e.g., standard of care). They might also comprise eclectic
interventions including naturalistic prescribing of medications, or
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minor systemic components (e.g., family member psycho-educa-
tion).
Structured or non-specific individual psychological therapies will
include manualised individual therapies, such as those based on
general approaches described in Types of interventions (e.g., cog-
nitive-behavioural), and other therapies for PTSD (e.g., eyemove-
ment desensitisation and reprocessing) (Bisson 2007). Non-spe-
cific individual psychological therapies provide generic features of
therapy, including clinical contact and human interaction (e.g.,
clinician warmth, empathy, social support), and a treatment ra-
tionale (Mohr 2009). As such, they may reflect practices that ap-
proximate supportive or humanistic therapy to varying degrees.
The aim of this review is not to consider the superiority of different
types of couple and family therapies. As such, we will exclude
comparisons among alternative couple or family therapies aswell as
comparisons with partial treatment controls (e.g., the same couple
or family intervention,minus key components of therapy thatmay
drive therapeutic change).
We will also exclude studies that compare a couple or family ther-
apy with an experimental pharmacological treatment (although
comparisons with individual therapies that involve naturalistic
prescribing of medications will be eligible).
Types of outcome measures
The current review will consider outcomes that address multiple
domains of individual, couple and family adjustment. Additional
outcomes, such as marital stability and observational measures of
marital interaction, as well as potential adverse events (e.g., sub-
stance abuse, self-harm) may be considered in updates as studies
and data become available.
Primary outcomes
1. Severity of PTSD symptoms, as demonstrated by the pri-
mary presenting patient and ascertained using self-reports or clin-
ician reports on measurement scales such as the PTSD Checklist
(Weathers 1993), the PTSD symptom scale (Foa 1993), as well
as the Clinician Administered PTSD Scale (Blake 1995); which is
considered a gold standard measure in many contexts (Weathers
2001)
2. Severity of psychological symptoms of family members, ascer-
tained using self-reports or clinician reports on measures of mental
health symptom severity (e.g., PTSD Checklist; Weathers 1993)
or psychological distress (e.g., the five-item Mental Health Index
of the 36-item Short Form health survey (SF-36); Ware 2000).
We will consider data from adult romantic partners and children
in the family separately where sufficient data are available
3. Dyadic adjustment, ascertained using self-report, family mem-
ber reports or clinician reports on measures of relationship satis-
faction or distress, like theDyadic Adjustment Scale or theMarital
Adjustment Test (Locke 1959; Spanier 1976)
Secondary outcomes
4. Severity of co-occurring depression or anxiety, as demonstrated
by the primary presenting patient and ascertained using self-re-
ports or clinician reports on measurement scales such as the Beck
Depression Inventory or the Beck Anxiety Inventory (Beck 1961;
Beck 1988)
5. Overall family functioning, ascertained using self-report, family
member reports or clinician reports of overall family functioning,
or specific characteristics of family interaction (e.g., communica-
tion), as measured through scales like the McMaster Family As-
sessment Device or the Family Environment Scale (Epstein 1983;
Moos 1986)
6. Treatment dropout will be used as a proxy measure of treatment
acceptability, and will be defined by the proportion of participants
in treatment and control conditions that provide data at the most
immediate post-treatment assessment.
7. Instances of severe aggression or violence will be considered as
a type of adverse event (see Christensen 2005). Other types of
adverse events (e.g., substance abuse, self-harm)may be considered
in updates of this review as data becomes available.
Multiple informants
When data on dyadic adjustment or family functioning are avail-
able from multiple family members (e.g., when both partners in a
couple report on relationship satisfaction), we will combine data
from multiple informants to make use of all available data. This
will be done be calculating the simple arithmetic mean of scores
(assuming that all family members provide reports on the same
scale) and the pooled variance. Exceptions may be where different
family members show widely divergent perspectives on relation-
ships, as demonstrated by limited shared variance (i.e., < 50% or
r = 0.70). In such instances, reports from different family mem-
bers may be considered in separate analyses. Assuming the most
studies will not provide data on shared variance, we will examine
the implications of decisions to average acrossmultiple informants
through sensitivity analyses.
Timing of outcome assessment
We will examine data from all outcomes at: (a) immediate post-
treatment assessments, conducted from 0 to 3 months following
the completion of therapy; and (b) follow-up assessments, con-
ducted more than 3 months but less than 12 months following
completion of therapy.Wewill also consider additional and longer
periods of follow-up assessment if relevant data are available.
Search methods for identification of studies
We will conduct a systematic search procedure to identify all
available relevant evidence. This systematic search procedure will
comprise two main strategies including: (1) electronic searches of
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databases and clinical trials registries; and (2) manual searches of
other resources.
Electronic searches
We will perform electronic searches of multiple databases. These
databases will include theCochraneDepression, Anxiety andNeu-
rosis Review Group’s Specialised Register (CCDANCTR), which
covers relevant RCTs indexed in EMBASE (1974-), MEDLINE
(1950-) and PsycINFO (1967-), as well as the Cochrane Central
Register of Controlled Trials (CENTRAL, The Cochrane Library,
all years). For a full description of the CCDANCTR, please see
Appendix 1.
We will also conduct supplementary searches of the following ad-
ditional databases:
• Literature in the Health Sciences in Latin America and the
Caribbean (LILACS);
• Published International Literature on Traumatic Stress
(PILOTS); and
• Web of Science.
We will search the CCDANCTR (Studies and References Regis-
ters) using the following free-text terms:
• (PTSD or post-trauma* or *trauma* or “stress disorder*” or
(combat and disorder*) or (war and neuro*)) AND (couple* or
partner* or marriage or marital or husband* or wife or wives* or
spous* or family or families or multi-family or conjoint or
interpersonal or relations* or (child* and parent*)) AND
(*therap* or counsel* or treat* or intervention*).
We will adapt these search terms to conduct analogous searches of
additional databases (e.g., PILOTS). We will apply no date or lan-
guage restrictions. We will also search theWorldHealthOrganiza-
tion (WHO) International Clinical Trials Registry Platform (IC-
TRP) search portal (http://apps.who.int/trialsearch/) and Clin-
icalTrials.gov (http://clinicaltrials.gov/) to identify unpublished
and/or ongoing studies.
Searching other resources
Handsearching
We will manually search the early editions of key journals to iden-
tify potentially relevant studies that may not be indexed in the
databases. These key journals will include:
• Journal of Traumatic Stress (1988 - 2000);
• Journal of Family Psychology (1987 - 2000); and
• Journal of Marital and Family Therapy (1980 - 2000).
Reference lists
We will also manually screen the reference lists and bibliographies
of all included studies to identify other relevant references.
Data collection and analysis
Selection of studies
We will select studies in stages. First, we will screen the titles and
abstracts (where available) of all records retrieved to determine
potentially eligible studies. Two review authors will screen each
record. We will obtain full-text articles of any studies that would
appear to meet inclusion criteria, as well as those that cannot be
excluded based on title and abstract, for further assessment. Two
review authors will independently examine each full-text article
in order to confirm eligibility, and disagreement will be resolved
through discussion. We will identify any duplicate publications
and list them along with the primary publication. We will record
and present decisions made during the study selection process, as
well as the names and numbers of studies and reasons for exclusion
at each stage, in aPreferredReporting Items for SystematicReviews
and Meta-Analyses (PRISMA) flow diagram.
Data extraction and management
Following the identification of eligible studies, we will extract data
on study characteristics from reports using a piloted, structured
data extraction template. Data extraction will endeavour to ob-
tain information (where available) relating to publication details
(e.g., country of origin, year of publication), sample characteris-
tics (e.g., age and ethnicity of participants, predominant type of
trauma), clinical characteristics (e.g., type of therapy, duration of
treatment), methodology (e.g., inclusion/exclusion criteria, tim-
ing of follow-up assessments), statistical analyses and results (e.g.,
strategies for managing non-independent data from family mem-
bers, group means and standard deviations for primary and sec-
ondary outcomes). Two review authors will independently extract
data from each study to ensure accuracy.
Main comparisons
Multiple comparisons are planned to evaluate the efficacy of stand-
alone couple or family therapies for PTSD compared to relevant
control comparators. These include:
1. couple or family therapy versus no treatment;
2. couple or family therapy versus standard care; and
3. couple or family therapy versus structured or non-specific
individual psychological therapy.
Additional comparisons are planned to evaluate the efficacy of
adjunctive couple or family therapies, additional to primary treat-
ment, relative to controls. These include:
1. couple or family therapy (adjunctive to standard care)
versus standard care alone;
2. couple or family therapy (adjunctive to structured or non-
specific individual psychological therapies) versus structured or
non-specific individual psychological therapies alone.
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Additional types of comparisons may be considered as studies be-
come available.
Comparisons involving adjunctive therapies will be limited to con-
trol conditions that involve substantively similar primary treat-
ments. As such, we will not consider comparisons between couple
or family therapies adjunctive to primary treatment and (a) ’no
treatment’ controls, and (b) substantively different primary treat-
ments (e.g., cognitive-behavioural therapy versus psychodynamic
individual therapy).Wheremultiple couple or family therapy con-
ditions are compared with control conditions, it is envisaged that
the couple or family therapy conditions will be combined (Unit
of analysis issues).
Assessment of risk of bias in included studies
Two review authors will independently assess risk of bias associ-
ated with each study. Both authors will allocate a judgement of
’High’, ’Low’ or ’Unclear’ risk of bias with regard to several design
characteristics that are among the main sources of bias in clini-
cal trials (Higgins 2011b). Disagreements between review authors
with regard to classification of studies will be resolved through
discussion. In line with available recommendations (Juni 1999),
we will assess each source of bias independently.
Random allocation to groups (sequence generation)
It is an eligibility requirement that studies use random allocation
to groups. Notwithstanding this, it is envisaged that the level of
detail published about randomisation procedures may vary. We
will classify studies which provide limited or no detail about ran-
domisation as having unclear risk of bias.
Allocation concealment
Adequate concealment of allocation requires that participants and
researchers are kept unaware, and are unable to foresee, the groups
to which participants are allocated (Schulz 2002). We will classify
studies that lack allocation concealment as having high risk of bias.
Blinding
Blinding can refer to hiding the nature of the intervention deliv-
ered from multiple potential groups (e.g., participants, treatment
providers, outcome assessors) (Montori 2002), and we will con-
sider the following blinding aspects.
1. Participants and treatment providers: blinding of
participants and treatment providers is usually easy to accomplish
in studies of pharmacological treatments, but it is rarely feasible
for psychological therapies. Accordingly, it is expected that most
studies will be classified as having a high risk of bias.
2. Outcome assessors: blinding of outcome assessment will
refer to masking of group allocation from outcome assessors (e.g.,
researchers administering symptom scales). Studies that fail to
blind outcome assessors (including studies relying on self-report
measures completed by participants) will be classified as having a
high risk of bias. Given that blinding of outcomes assessors may
vary within studies and across outcomes (e.g., some may be self-
reported with other outcomes evaluated using blinded outcome
assessors), this characteristic will be assessed separately for each
outcome considered in Types of outcome measures.
Incomplete outcome data
According to Higgins 2011b, missing data can be caused by both
study exclusions and attrition. Justifiable reasons for exclusions
may include identifying (after randomisation) that participants
were ineligible for the study. In contrast, participants may be ex-
cluded because they did not receive the intended intervention
in accordance with the protocol (or for other reasons), which
may lead to bias (Higgins 2011b). In case of missing data from
attrition, primary studies may report analyses conducted using
data fromparticipants providing complete information (i.e., ’com-
pleters only’), or by including data from all participants through
use of variousmissing data strategies. These include recommended
strategies based on principles of maximum-likelihood or multiple
imputation, as well as older (and potentially biased) forms of im-
putation including mean imputation and last observation carried
forward (LOCF) (Graham 2009).
For the purpose of this review, we will classify studies as having a
high risk of bias if they violate any of three principles of intention-
to-treat (ITT) analyses described by Higgins 2011b. These are:
1. “keep participants in the intervention groups to which they
were randomised, regardless of the intervention they received”;
2. “measure outcome data on all participants”; and
3. “include all randomised participants in the analyses”.
Given that approaches to managing incomplete outcome data
(from attrition in particular) may vary within studies and across
outcomes, we will assess these approaches separately for each out-
come considered in Types of outcome measures.
Selective outcome reporting
Selective outcome reporting refers to the presentation of a lim-
ited subset of data or analyses based on the nature (e.g., statistical
significance) of results (Hutton 2000). Although there are various
issues suggestive of selective outcome reporting (Higgins 2011b),
we will classify studies in this review as having high risk of bias if
they have protocols or entries in trial registries that list primary or
secondary outcomes that differ from those reported in the pub-
lished results (lacking credible explanation). We will classify stud-
ies that are not associated with published protocols or adequately
detailed entries in trial registries as having an unclear risk of bias.
Measures of treatment effect
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Dichotomous data
For evaluation of treatment effects based on dichotomous out-
comes (e.g., scores in the clinically significant range on relation-
ship adjustment), we will use the risk ratios (RRs) and associated
95% confidence intervals (CIs).
Continuous data
For evaluation of treatment effects based on continuous outcomes
we will use the mean differences (MDs), where outcomes are re-
ported on the same scale, or the standardised mean difference
(SMDs) where outcomes are reported on different scales. We will
obtain SMDs by calculating the difference between raw means
and dividing by the pooled variance of treatment and control con-
ditions. We will present 95% CIs around the MDs or SMDs.
Unit of analysis issues
Cluster-randomised trials
Where a cluster-randomised trial is identified, we will extract the
methods used to analyse data, while the inflated standard error
approach will be used to adjust standard errors for non-indepen-
dence of observations (Higgins 2011c). To facilitate this, we will
extract the degree of non-independence, as reflected in the intra-
class correlation (ICC). Where the ICC is not reported, a value of
0.05 will be assumed.
Cross-over trials
Where a cross-over trial is identified, we will consider data from
the between-group comparison from the first treatment stage only.
Studies with multiple treatment groups
Wheremultiple couple or family therapy conditions are compared
with a ’no treatment’ or individual intervention control, we will
combine the couple or family therapy conditions using the formu-
lae reported by Higgins 2011a. Exceptions may be where a stand-
alone couple or family therapy and an adjunctive therapy (along-
side another primary treatment) are both compared with an indi-
vidual therapy condition, and where the adjunctive condition pro-
vides a significant additional dosage of therapy (in terms of number
of sessions). Rather, we will evaluate stand-alone and adjunctive
therapy conditions in separate comparisons (Data extraction and
management). Where different groups are involved in the same
treatment, but have results reported separately, we will also com-
bine these data.
Dealing with missing data
Missing information about study design and results/statistics
Information about research design that is not reported in a primary
publication will be initially ascertained through examination of
duplicate publications. Where informative duplicate publications
are unavailable, and where missing data relate to the inclusion
criteria or risk of bias (as defined in this review), we will contact
the study authors for additional information. We will also seek
clarification from the study authors where statistics necessary for
the estimation of treatment effects (e.g., standard deviations) are
missing.
Missing observations from primary studies due to attrition
Our decision to consider ’completers only’ data or data from all
participants will be initially determined by the type of information
reported; for example, if the study only reports analyses of the
’completers only’ sample.However, preference will be given to data
from all randomised participants (where available). Given certain
’old’ missing data strategies (such as mean or single imputation
or LOCF) that may still introduce bias into the study (Graham
2009), we will examine these through sensitivity analyses.
Assessment of heterogeneity
Clinical heterogeneity
For studies that are clinically heterogeneous or present insufficient
information to facilitate quantitative synthesis, we will present a
narrative summary of results.
Statistical heterogeneity
We will assess statistical heterogeneity across studies using the I2
statistic, which indicates the percentage of total variability across
studies that is due to between-study differences (Huedo-Medina
2006). We will also examine the Chi2 statistic and associated sig-
nificance test (P value). However, this statistic lacks power to de-
tect true differences (Deeks 2011), and greater emphasis will thus
be placed on I2.
Although thresholds for I2 are arbitrary, there are overlapping
bands that may suggest minor (0% to 40%), moderate (30% to
60%), substantial (50%to90%), and considerable (75%to 100%)
levels of heterogeneity (Deeks2011). Interpretationof the I2 statis-
tic will be qualified through evaluation of the pattern of variabil-
ity, and whether all studies indicate beneficial effects of treatment.
Where strong evidence of true heterogeneity is present, the pooled
effect will be considered as a limited, though ’best available’ esti-
mate of the expected magnitude of the treatment effect.
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Assessment of reporting biases
Wewill examine multiple databases to identify published research,
while trial registers will be searched to identify unpublished stud-
ies. We will use funnel plots and the linear regression test to eval-
uate publication bias where there are more than k = 10 studies
available (Egger 1997: Sterne 2011). We will also screen relevant
databases and trial registers to identify reports published in a non-
English language.
Data synthesis
Two authors will enter data into the Cochrane Collaboration sta-
tistical software, Review Manager 2014, and we will employ the
random-effects model to provide a weighted estimate of the effi-
cacy of each intervention relative to control. This random-effects
model assumes true variability in effect sizes across studies, and
estimates both the average effect and degree of variability across
studies (Normand 1999). Where there is evidence of true het-
erogeneity, it may be inappropriate to place inordinate emphasis
on a weighted mean effect size (especially if some studies indicate
harmful effects) and we will instead interpret the pooled estimates
through discussion of statistical diversity of studies.
Subgroup analysis and investigation of heterogeneity
In the case of observed statistical heterogeneity, and where suffi-
cient studies are available, we will pursue subgroup analyses to ex-
amine factors explaining between-study variability. We will evalu-
ate potential differences in treatment effects according to the fol-
lowing study characteristics.
1. Disorder-specific versus generic couple or family therapies:
Disorder-specific and generic therapies share a focus on
improved relationship outcomes. However, disorder-specific
therapies may include additional components of treatment
targeting individual psychopathology, and may thus have greater
impacts on individual post-traumatic symptoms. The more
singular focus of generic therapies on relationship problems may
lead to larger improvements in couple and family adjustment.
2. Nature of trauma linked to disorder onset: Patients exposed
to interpersonal trauma (e.g., sexual assault) may demonstrate
greater severity of problems in couple and family functioning,
relative to traumas that do not have equivalent interpersonal
components (e.g., combat exposure, natural disasters).
Accordingly, disorders associated with interpersonal trauma may
benefit more from couple and family therapies.
3. Recent onset versus chronic PTSD: Disorders with recent
onset (e.g., within one year of trauma exposure) may be more
amenable to change following couple and family therapies for
PTSD, relative to longer-standing conditions where symptoms
and interpersonal patterns have become established over time.
We will conduct the above subgroup analyses using the approach
described by Deeks 2011, applying the test for subgroup differ-
ences available in Review Manager 2014. We may consider other
potential clinical characteristics (e.g., couple versus family-based
therapies for PTSD) in updates as studies and literature becomes
available.
Sensitivity analysis
We will conduct sensitivity analyses to examine whether findings
are robust to approaches adopted in this review (Deeks 2011). We
will consider the following characteristics of assumptions sequen-
tially for the purposes of these analyses.
• Where outcome data from multiple informants are
available, we will exclude data from family members.
• We will exclude cluster randomised trials.
• We will vary the ICC used during analyses of cluster
randomised trials.
• We will exclude cross-over trials.
• Results based on ‘completers only’ will be excluded.
• Results based on imputed values for missing data will be
imputed.
Summary of findings table
Summary of findings tables will be developed to summarise the
key findings of the review, for all relevant populations, in line
with Schünemann 2011. The tables will present findings relating
to each type of intervention in terms of primary and secondary
outcomes (Types of outcome measures), standardised effect size
estimates (and 95% CIs) to illustrate comparative risk, the num-
ber of studies and participants, and the quality of evidence based
on standards of the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) working group (Balshem
2011).
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A P P E N D I C E S
Appendix 1. Further information on CCDANCTR
The Cochrane Depression, Anxiety and Neurosis Group (CCDAN) maintain two clinical trials registers at their editorial base in
Bristol, UK, a references register and a studies based register. The CCDANCTR-References Register contains over 33,000 reports of
randomised controlled trials in depression, anxiety and neurosis. Approximately 60% of these references have been tagged to individual,
coded trials. The coded trials are held in the CCDANCTR-Studies Register and records are linked between the two registers through
the use of unique Study ID tags. Coding of trials is based on the EU-Psi coding manual. Please contact the CCDAN Trials Search
Coordinator for further details. Reports of trials for inclusion in the Group’s registers are collated from routine (weekly), generic
searches of MEDLINE (1950-), EMBASE (1974-) and PsycINFO (1967-); quarterly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL) and review specific searches of additional databases. Reports of trials are also retrieved from WHO
ICTRP search portal, ClinicalTrials.gov, drug companies, the hand-searching of key journals, conference proceedings and other (non-
Cochrane) systematic reviews and meta-analyses. Details of CCDAN’s generic search strategies can be found on the Group’s website.
The CCDANCTR is hosted and maintained on the new Cochrane Register of Studies (CRS) meta-register, which allows for left- and
right-hand truncation of search terms.
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